Detalhe da pesquisa
1.
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
Breast Cancer Res Treat
; 189(1): 103-110, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120223
2.
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort.
Am J Hematol
; 96(4): 428-435, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421178
3.
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Br J Clin Pharmacol
; 86(9): 1836-1848, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32207164
4.
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
Cancer
; 125(4): 533-540, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30570744
5.
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Cancer
; 125(7): 1113-1123, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30690710
6.
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med
; 375(18): 1738-1748, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717303
7.
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 168(1): 127-134, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164421
8.
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 167(3): 659-669, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29058175
9.
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
Oncologist
; 22(3): 264-271, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209746
10.
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.
Int J Cancer
; 139(1): 177-86, 2016 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891420
11.
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.
Lancet Oncol
; 16(3): 338-48, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701170
12.
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma.
Haematologica
; 100(5): 670-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25710456
13.
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.
Invest New Drugs
; 32(4): 682-90, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24691674
14.
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Adv Ther
; 38(1): 350-365, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123968
15.
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients.
NPJ Breast Cancer
; 7(1): 77, 2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117261
16.
Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study.
Clin Breast Cancer
; 18(5): e781-e787, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29678476
17.
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial.
JAMA Oncol
; 4(10): 1344-1351, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29978216
18.
Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial.
Clin Genitourin Cancer
; 5(7): 427-32, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18272024
19.
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.
Lung Cancer
; 54(1): 69-77, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16934909
20.
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 22(13): 3157-63, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847057